Clinical Trial: A Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy

Press/Media: Press / Media

Period2022 Apr 22

Media coverage

2

Media coverage

  • TitleClinical Trial: A Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy
    Media name/outletHealth Daily Digest (Ht Media)
    Country/TerritoryIndia
    Date22/4/22
    PersonsYong Ho Lee, Young-Sun Lee, Young-sun Lee, Yong-Sook Lee
  • TitleClinical Trial: A Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy
    Media name/outletUS Fed News
    Country/TerritoryUnited States
    Date22/4/22
    PersonsYong Ho Lee, Young-Sun Lee, Young-sun Lee, Yong-Sook Lee